| Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate-and high-risk men AE Ross, MH Johnson, K Yousefi, E Davicioni, GJ Netto, L Marchionni, ... European urology 69 (1), 157-165, 2016 | 262 | 2016 |
| MSH2 loss in primary prostate cancer LB Guedes, ES Antonarakis, MT Schweizer, N Mirkheshti, F Almutairi, ... Clinical cancer research 23 (22), 6863-6874, 2017 | 150 | 2017 |
| Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis B Benzon, SG Zhao, MC Haffner, M Takhar, N Erho, K Yousefi, P Hurley, ... Prostate cancer and prostatic diseases 20 (1), 28-35, 2017 | 145 | 2017 |
| Prevalence and prognostic significance of PTEN loss in African-American and European-American men undergoing radical prostatectomy JJ Tosoian, F Almutairi, CL Morais, S Glavaris, J Hicks, D Sundi, ... European urology 71 (5), 697-700, 2017 | 75 | 2017 |
| Genome-wide association and multi-omic analyses reveal ACTN2 as a gene linked to heart failure M Arvanitis, E Tampakakis, Y Zhang, W Wang, A Auton, D Dutta, ... Nature communications 11 (1), 1122, 2020 | 64 | 2020 |
| SPINK1 defines a molecular subtype of prostate cancer in men with more rapid progression in an at risk, natural history radical prostatectomy cohort MH Johnson, AE Ross, M Alshalalfa, N Erho, K Yousefi, S Glavaris, ... The Journal of urology 196 (5), 1436-1444, 2016 | 49 | 2016 |
| Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer B Benzon, SA Glavaris, BW Simons, RM Hughes, K Ghabili, P Mullane, ... Prostate cancer and prostatic diseases 21 (1), 126-136, 2018 | 45 | 2018 |
| Circulating tumor cell and circulating tumor DNA assays reveal complementary information for patients with metastatic urothelial cancer HJ Chalfin, SA Glavaris, MA Gorin, MR Kates, MH Fong, L Dong, ... European urology oncology 4 (2), 310-314, 2021 | 35 | 2021 |
| Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer BL Maughan, DL Suzman, B Luber, H Wang, S Glavaris, R Hughes, ... Cancer chemotherapy and pharmacology 78, 1297-1304, 2016 | 29 | 2016 |
| Analogous detection of circulating tumor cells using the AccuCyte®—CyteFinder® system and ISET system in patients with locally advanced and metastatic … EE van der Toom, VP Groot, SA Glavaris, G Gemenetzis, HJ Chalfin, ... The Prostate 78 (4), 300-307, 2018 | 24 | 2018 |
| Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy AE Ross, RM Hughes, S Glavaris, K Ghabili, P He, NM Anders, R Harb, ... Oncotarget 8 (61), 104182, 2017 | 24 | 2017 |
| Prostate cancer disseminated tumor cells are rarely detected in the bone marrow of patients with localized disease undergoing radical prostatectomy across multiple rare cell … HJ Chalfin, SA Glavaris, PD Malihi, JM Sperger, MA Gorin, C Lu, ... The Journal of urology 199 (6), 1494-1501, 2018 | 22 | 2018 |
| Characterization of urothelial cancer circulating tumor cells with a novel selection-free method HJ Chalfin, M Kates, EE van der Toom, S Glavaris, JE Verdone, NM Hahn, ... Urology 115, 82-86, 2018 | 20 | 2018 |
| Nucleolin staining may aid in the identification of circulating prostate cancer cells HJ Chalfin, JE Verdone, EE van der Toom, S Glavaris, MA Gorin, ... Clinical genitourinary cancer 15 (3), e477-e481, 2017 | 20 | 2017 |
| Heart neurons use clock genes to control myocyte proliferation E Tampakakis, H Gangrade, S Glavaris, M Htet, S Murphy, BL Lin, T Liu, ... Science advances 7 (49), eabh4181, 2021 | 17 | 2021 |
| Clinical validation of the 2005 ISUP Gleason grading system in a cohort of intermediate and high risk men undergoing radical prostatectomy SF Faraj, SM Bezerra, K Yousefi, H Fedor, S Glavaris, M Han, AW Partin, ... PloS one 11 (1), e0146189, 2016 | 17 | 2016 |
| GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States I Vidal, Q Zheng, JL Hicks, J Chen, EA Platz, BJ Trock, I Kulac, ... PLoS One 16 (6), e0241934, 2021 | 12 | 2021 |
| Predicting prostate cancer molecular subtype with deep learning on histopathologic images E Erak, LDP Oliveira, AA Mendes, O Dairo, O Ertunc, I Kulac, ... Modern Pathology 36 (10), 100247, 2023 | 6 | 2023 |
| Ten unanswered questions in cancer:“If this is true, what does it imply”? SR Amend, AE de Groot, G Torga, HD Axelrod, DK Reyes, KC Valkenburg, ... American journal of clinical and experimental urology 6 (2), 26, 2018 | 6 | 2018 |
| TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers TD Nichakawade, J Ge, BJ Mog, BS Lee, AH Pearlman, MS Hwang, ... Nature 628 (8007), 416-423, 2024 | 4 | 2024 |
